Protagonist Therapeutics, Inc. (PTGX)

Last Closing Price: 47.58 (2025-05-29)

Earnings Announcements: Estimated vs Actual

On 2025-05-06, Protagonist Therapeutics, Inc. (PTGX) announced earnings per share of $-0.19 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.50.

The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.53 for the fiscal quarter ending 2025-06-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.

Announcement Date Fiscal Quarter End Estimated EPS Actual EPS
2025-05-06 2025-03-31 $-0.50 $-0.19
2025-02-21 2024-12-31 $0.06 $1.98
2024-11-07 2024-09-30 $-0.59 $-0.54
2024-08-06 2024-06-30 $-0.50 $-0.50
2024-05-07 2024-03-31 $2.51 $3.26
2024-02-27 2023-12-31 $-0.16 $0.44
2023-11-02 2023-09-30 $-0.68 $-0.58
2023-08-03 2023-06-30 $-0.65 $-0.68
2023-05-04 2023-03-31 $-0.69 $-0.67
2023-03-15 2022-12-31 $-0.67 $-0.69
2022-11-08 2022-09-30 $-0.94 $-0.64
2022-08-04 2022-06-30 $-0.99 $-0.84
2022-05-04 2022-03-31 $-0.67 $-0.43
2022-02-28 2021-12-31 $-0.79 $-0.77
2021-11-03 2021-09-30 $-0.67 $-0.70
2021-08-04 2021-06-30 $-0.62 $-0.69
2021-05-04 2021-03-31 $-0.57 $-0.54
2021-03-10 2020-12-31 $-0.47 $-0.48
2020-11-04 2020-09-30 $-0.61 $-0.21
2020-08-06 2020-06-30 $-0.57 $-0.59
2020-05-07 2020-03-31 $-0.64 $-0.72
2020-03-10 2019-12-31 $-0.64 $-0.63
2019-11-06 2019-09-30 $-0.75 $-0.61
2019-08-07 2019-06-30 $-0.27 $-1.18
2019-05-08 2019-03-31 $-0.65 $-0.58
2019-03-12 2018-12-31 $-0.42 $-0.57
2018-11-06 2018-09-30 $-0.40 $-0.38
2018-08-07 2018-06-30 $-0.30 $-0.41
2018-05-09 2018-03-31 $-0.24 $-0.36
2018-03-07 2017-12-31 $-0.36 $-0.15
2017-11-06 2017-09-30 $-0.95 $-0.29
2017-08-08 2017-06-30 $-0.92 $-0.89
2017-05-10 2017-03-31 $-0.64 $-0.84
2017-03-07 2016-12-31 $-0.49 $-0.67
2016-11-14 2016-09-30 $-0.49 $-0.87
2016-09-15 2016-06-30 $-1.07 $-19.07